IP Library Granted Patent US 9,233,245
Granted Patent B2
US 9,233,245 · App. 14/588,531 · Granted Jan 12, 2016

SPG stimulation

Inventors: Itschak Lamensdorf (Modiin, IL); Avinoam Dayan (Zikron Yaakov, IL); Hernan Altman (Tivon, IL)
Assignee: BRAINSGATE LTD.
A61N1/36057A61N1/0548A61N1/3606A61N1/36017A61N1/0546A61N1/205A61N1/37229
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,233,245
App. No.
14/588,531
Granted
Jan 12, 2016
Kind
B2
Abstract

A method for treating a subject is provided, including applying electrical stimulation to a site of the subject selected from the group consisting of: a sphenopalatine ganglion (SPG), a greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, and a lesser deep petrosal nerve. The stimulation is configured to excite nervous tissue of the site at a strength sufficient to induce at least one neuroprotective occurrence selected from the group consisting of: an increase in cerebral blood flow (CBF) of the subject, and a release of one or more neuroprotective substances, and insufficient to induce a significant increase in permeability of a blood-brain barrier (BBB) of the subject.

Claims (11)

1. A method for treating a subject, comprising:

applying electrical stimulation to a site of the subject selected from the group consisting of: a sphenopalatine ganglion (SPG), a greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, and a lesser deep petrosal nerve; and

configuring the stimulation to excite nervous tissue of the site at a strength that (a) is sufficient to induce at least one neuroprotective occurrence selected from the group consisting of: an increase in cerebral blood flow (CBF) of the subject, and a release of one or more neuroprotective substances, and (b) is insufficient to induce a significant increase in permeability of a blood-brain barrier (BBB) of the subject.

2. The method according to claim 1 , wherein configuring the stimulation comprises setting the strength to less than 90% of a strength sufficient to induce the significant increase in the permeability of the BBB.

3. The method according to claim 1 , wherein configuring the stimulation comprises setting the strength to less than 40% of a strength sufficient to induce the significant increase in the permeability of the BBB.

4. The method according to claim 1 , wherein configuring the stimulation comprises setting the strength to more than 50% of a strength sufficient to induce the significant increase in the permeability of the BBB.

5. The method according to claim 1 , wherein the site includes the SPG, and wherein applying the stimulation comprises applying the stimulation to the SPG.

6. The method according to claim 5 , wherein applying the stimulation comprises:

placing an elongated support element within a greater palatine canal of the subject, sized to extend from a palate of the subject to the SPG, and having a distal end; and

applying the stimulation from a vicinity of the distal end of the support element.

7. The method according to claim 1 , wherein configuring the stimulation comprises configuring the stimulation to induce the at least one neuroprotective occurrence without producing a measurably-harmful clinical effect for the subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2015
From: LAMENSDORF, ITSCHAK; DAYAN, AVINOAM; ALTMAN, HERNAN
To: BRAINSGATE LTD.
Reel/Frame 036123/0038 →
Continuity (10)
Continuation In Part 12983409 · Jan 3, 2011
Continuation 12052788 · Mar 21, 2008
Division 11349020 · Feb 7, 2006
Continuation In Part 10783113 · Feb 20, 2004
Continuation In Part 14588531
Continuation In Part 13849673 · Mar 25, 2013
Division 13223929 · Sep 1, 2011
Division 11465381 · Aug 17, 2006
Provisional Application 60709734 · Aug 19, 2005
Related Publication 20150174406A1 · Jun 25, 2015